Hassan S - Search Results

1

Expanding the Use of PARP Inhibitors as Monotherapy and in Combination in Triple-Negative Breast Cancer.

Yordanova M, Hubert A, Hassan S. Yordanova M, et al. Among authors: hassan s. Pharmaceuticals (Basel). 2021 Dec 6;14(12):1270. doi: 10.3390/ph14121270. Pharmaceuticals (Basel). 2021. PMID: 34959671 Free PMC article. Review.

2

Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer.

Hassan S, Esch A, Liby T, Gray JW, Heiser LM. Hassan S, et al. Mol Cancer Ther. 2017 Dec;16(12):2892-2901. doi: 10.1158/1535-7163.MCT-17-0170. Epub 2017 Sep 27. Mol Cancer Ther. 2017. PMID: 28958991 Free PMC article.

3

The Role of the 21-Gene Recurrence Score^® Assay in Hormone Receptor-Positive, Node-Positive Breast Cancer: The Canadian Experience.

Yordanova M, Hassan S. Yordanova M, et al. Among authors: hassan s. Curr Oncol. 2022 Mar 16;29(3):2008-2020. doi: 10.3390/curroncol29030163. Curr Oncol. 2022. PMID: 35323363 Free PMC article. Review.

4

Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer.

Beniey M, Hubert A, Haque T, Cotte AK, Béchir N, Zhang X, Tran-Thanh D, Hassan S. Beniey M, et al. Among authors: hassan s. Br J Cancer. 2023 May;128(10):1964-1975. doi: 10.1038/s41416-023-02226-w. Epub 2023 Mar 20. Br J Cancer. 2023. PMID: 36941406 Free PMC article.

5

Translating the role of PARP inhibitors in triple-negative breast cancer.

Beniey M, Haque T, Hassan S. Beniey M, et al. Among authors: hassan s. Oncoscience. 2019 Jan 31;6(1-2):287-288. doi: 10.18632/oncoscience.474. eCollection 2019 Jan. Oncoscience. 2019. PMID: 30800714 Free PMC article. No abstract available.

6

Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer.

Cavallone L, Aguilar-Mahecha A, Lafleur J, Brousse S, Aldamry M, Roseshter T, Lan C, Alirezaie N, Bareke E, Majewski J, Ferrario C, Hassan S, Discepola F, Seguin C, Mihalcioiu C, Marcus EA, Robidoux A, Roy JA, Pelmus M, Basik M. Cavallone L, et al. Among authors: hassan s. Sci Rep. 2020 Sep 7;10(1):14704. doi: 10.1038/s41598-020-71236-y. Sci Rep. 2020. PMID: 32895401 Free PMC article.

7

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.

Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Untch M, Fasching PA, Cardoso F, Andersen J, Patt D, Danso M, Ferreira M, Mouret-Reynier MA, Im SA, Ahn JH, Gion M, Baron-Hay S, Boileau JF, Ding Y, Tryfonidis K, Aktan G, Karantza V, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2022 Feb 10;386(6):556-567. doi: 10.1056/NEJMoa2112651. N Engl J Med. 2022. PMID: 35139274 Clinical Trial.

8

Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec.

Hassan S, Younan R, Patocskai E, Provencher L, Poirier B, Sideris L, Dubé P, Mihalcioiu C, Chabot-Blanchet M, Guertin MC, Boileau JF, Robidoux A. Hassan S, et al. Oncologist. 2022 Oct 1;27(10):822-831. doi: 10.1093/oncolo/oyac123. Oncologist. 2022. PMID: 35830543 Free PMC article.

9

Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers.

Hamel S, Bouchard A, Ferrario C, Hassan S, Aguilar-Mahecha A, Buchanan M, Quenneville L, Miller W, Basik M. Hamel S, et al. Among authors: hassan s. Breast Cancer Res Treat. 2010 Feb;120(1):47-57. doi: 10.1007/s10549-009-0364-7. Epub 2009 Mar 20. Breast Cancer Res Treat. 2010. PMID: 19301121

10

The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.

Légaré S, Cavallone L, Mamo A, Chabot C, Sirois I, Magliocco A, Klimowicz A, Tonin PN, Buchanan M, Keilty D, Hassan S, Laperrière D, Mader S, Aleynikova O, Basik M. Légaré S, et al. Among authors: hassan s. Cancer Res. 2015 Oct 15;75(20):4351-63. doi: 10.1158/0008-5472.CAN-14-3475. Epub 2015 Aug 21. Cancer Res. 2015. PMID: 26297734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,911 results

Search Page